Alps Group Inc
ALPSNASDAQHealthcareBiotechnology
Previous close
$0.32
+$0.05 · +18.52%
ALPS company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
44
Fair Value
Momentum
20
Strong Down
Sentiment
50
Mixed
Risk resilience
33
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAlps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- MY
- CEO
- Seng Kong Tham
- Listed since
- Oct 31, 2025
- Employees
- 2
Market position
Day range
Current $0.32
52-week range
Current $0.32
- Open
- $0.2775
- Previous close
- $0.27
- Volume
- 61.88K
- 0.7× average
- Average volume
- 88.88K
- Average daily volume
- Market cap
- 53.25M USD
- Beta
- -0.06
- Market reference 1
- 50-day average
- $0.5034
- -36.43% below average
- 200-day average
- $0.8312
- -61.50% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 45M USD
- P/E (TTM)
- -0.02×
- P/B (TTM)
- -0.38×
- P/S (TTM)
- 15.8×
- EV / EBITDA
- -33.27×
- Earnings yield
- -5.67%
- Free cash flow yield
- -3.82%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 38.60%
- Operating margin
- -1983.07%
- Net margin
- -2004.52%
- Return on equity
- 282.88%
- Return on assets
- -35.24%
- Return on invested capital
- 1872.65%
Financial health
- Debt / equity
- -0.19×
- Current ratio
- 0.2×
- Altman Z-score
- -31.33
- Piotroski F-score
- 4 of 9
Earnings
- Latest EPS result
- -14.11
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
ALPS news
ALPS peers
Continue in GoAI
Research ALPSresearch.disclaimer